ÂÜÀòÂÒÂ×

Mohammad Rafi has extensive experience in pharmacovigilance, currently serving as a Pharmacovigilance Associate at the Indian Pharmacopoeia Commission since April 2011, focusing on quality review of Individual Case Safety Reports (ICSRs) and Serious Unexpected Serious Adverse Reactions (SUSAR) identification. Previously, as a Technical Associate, Mohammad conducted seriousness and causality assessments of ICSRs and maintained safety databases at the same institution. Mohammad Rafi established the Pharmacovigilance department and promoted adverse drug reaction reporting at a hospital connected with a medical college in India while working at the Central Drugs Standard Control Organization from November 2010 to March 2011. An internship in Drug Safety & Epidemiology at Novartis India provided Mohammad Rafi with experience in safety case processing using ARGUS 8.0. Academic qualifications include a Master of Pharmacy in Pharmacovigilance from NIMS University and a Bachelor of Pharmacy from Vikram University, alongside formative education in various institutions from Libya and India.